A novel approach to patients with schizophrenia and type 2 diabetes showing low treatment compliance
Introduction Patients with schizophrenia usually demonstrate low compliance to medication. This could be a component of the disorder or a fact that they are not being properly cared. Objectives To prevent this in, we tried to treat these patients with long term action antidiabetic agents, in orde...
Main Authors: | P. Argitis, A. Karampas, P. Bringiotti, S. Karavia, O. Pikou, F.-E. Kakavitsas |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822019836/type/journal_article |
Similar Items
-
Antipsychotics induced constipation in patients with mental disorders. treatment suggestion with prucalopride in refractory cases. case report and literature review
by: P. Mpouras, et al.
Published: (2022-06-01) -
Protocol for the safety of brodalumab regarding psychiatric comorbidities in patients with psoriasis
by: O. Pikou, et al.
Published: (2022-06-01) -
Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study
by: Wendy A. Davis, et al.
Published: (2022-12-01) -
Intellectual decline in patients with schizophrenia with comorbid type ii diabetes mellitus and alcoholism
by: G. Р. Kostyuk, et al.
Published: (2022-01-01) -
Clinical features, effectiveness of therapy and quality of life of patients with type 2 diabetes and comorbid schizophrenia
by: M. Artemieva, et al.
Published: (2021-04-01)